Sotera Health Co
SHCUS売上高
$1.2B
百万USD
営業利益
-
百万USD
純利益
$78M
百万USD
ROE
12.9%
最新FY
EPS
$0.27
USD / 株
配当
-
USD / 株
業績推移
収益性
キャッシュフロー
財務状況
四半期業績
| 年度 | 期 | 売上高 | 純利益 | EPS |
|---|---|---|---|---|
| FY2021 | Q1 | $212M | $11M | $0.04 |
| FY2021 | Q2 | $252M | $43M | $0.15 |
| FY2021 | Q3 | $226M | $27M | $0.10 |
| FY2021 | FY | $931M | $117M | $0.41 |
| FY2022 | Q1 | $237M | $31M | $0.11 |
| FY2022 | Q2 | $267M | $30M | $0.11 |
| FY2022 | Q3 | $249M | $25M | $0.09 |
| FY2022 | FY | $1.0B | $-234M | $-0.83 |
| FY2023 | Q1 | $221M | - | $0.01 |
| FY2023 | Q2 | $255M | $24M | $0.08 |
| FY2023 | Q3 | $263M | $-14M | $-0.05 |
| FY2023 | FY | $1.0B | $51M | $0.18 |
| FY2024 | Q1 | $248M | - | $0.02 |
| FY2024 | Q2 | $277M | $9M | $0.03 |
| FY2024 | Q3 | $285M | $17M | $0.06 |
| FY2024 | FY | $1.1B | $44M | $0.16 |
| FY2025 | Q1 | $255M | - | $-0.05 |
| FY2025 | Q2 | $294M | $8M | $0.03 |
| FY2025 | Q3 | $311M | $48M | $0.17 |
| FY2025 | FY | $1.2B | $78M | $0.27 |
| FY2026 | Q1 | $280M | $27M | $0.09 |
財務データ
| 指標 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| 売上高 | $931M | $1.0B | $1.0B | $1.1B | $1.2B |
| 営業利益 | $257M | $248M | $277M | $298M | - |
| 純利益 | $117M | $-234M | $51M | $44M | $78M |
| 総資産 | $2.8B | $3.1B | $3.1B | $3.1B | $3.3B |
| 純資産 | $586M | $350M | $444M | - | - |
| 自己資本 | $586M | $350M | $444M | $405M | $606M |
| 営業CF | $282M | $278M | $-148M | $224M | $287M |
| EPS | $0.41 | $-0.83 | $0.18 | $0.16 | $0.27 |
| BPS | $2.07 | $1.24 | $1.57 | $1.43 | $2.13 |
| ROE | 19.9% | -66.7% | 11.6% | 11.0% | 12.9% |